SHARON BENSON: Open Payments
NPI 1285958413 · NORTH SMITHFIELD, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,652 in 89 payments from 42 companies in 2025. Trend: 2023 $2,606 · 2024 $2,765 · 2025 $2,652
Food & beverage: $2,201Education: $451
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $309 |
| Novartis Pharmaceuticals Corporation | 8 | $174 |
| Astellas Pharma US Inc | 4 | $173 |
| PFIZER INC. | 8 | $150 |
| SOBI, INC | 3 | $149 |
| EMD Serono, Inc. | 1 | $126 |
| Daiichi Sankyo Inc. | 5 | $126 |
| AstraZeneca Pharmaceuticals LP | 4 | $124 |
| JAZZ PHARMACEUTICALS INC. | 1 | $90 |
| ABBVIE INC. | 4 | $88 |
Products named: RYBREVANT, ZEPZELCA, DARZALEX, DATROWAY, REBLOZYL, Padcev, TAVALISSE, KISQALI.
Industry payments across RI — which companies pay providers there.
